Literature DB >> 17694436

Neurocognitive effects of methamphetamine: a critical review and meta-analysis.

J Cobb Scott1, Steven Paul Woods, Georg E Matt, Rachel A Meyer, Robert K Heaton, J Hampton Atkinson, Igor Grant.   

Abstract

This review provides a critical analysis of the central nervous system effects of acute and chronic methamphetamine (MA) use, which is linked to numerous adverse psychosocial, neuropsychiatric, and medical problems. A meta-analysis of the neuropsychological effects of MA abuse/dependence revealed broadly medium effect sizes, showing deficits in episodic memory, executive functions, information processing speed, motor skills, language, and visuoconstructional abilities. The neuropsychological deficits associated with MA abuse/dependence are interpreted with regard to their possible neural mechanisms, most notably MA-associated frontostriatal neurotoxicity. In addition, potential explanatory factors are considered, including demographics (e.g., gender), MA use characteristics (e.g., duration of abstinence), and the influence of common psychiatric (e.g., other substance-related disorders) and neuromedical (e.g., HIV infection) comorbidities. Finally, these findings are discussed with respect to their potential contribution to the clinical management of persons with MA abuse/dependence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17694436     DOI: 10.1007/s11065-007-9031-0

Source DB:  PubMed          Journal:  Neuropsychol Rev        ISSN: 1040-7308            Impact factor:   7.444


  182 in total

1.  Abnormal cerebral perfusion in chronic methamphetamine abusers: a study using 99MTc-HMPAO and SPECT.

Authors:  M Iyo; H Namba; M Yanagisawa; S Hirai; N Yui; S Fukui
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1997-07       Impact factor: 5.067

2.  Shape changes of the corpus callosum in abstinent methamphetamine users.

Authors:  Jungsu S Oh; In Kyoon Lyoo; Young Hoon Sung; Jaeuk Hwang; Jihyun Kim; Ain Chung; Kwang Suk Park; Seog Ju Kim; Perry F Renshaw; In Chan Song
Journal:  Neurosci Lett       Date:  2005 Aug 12-19       Impact factor: 3.046

3.  Decreased frontal white-matter integrity in abstinent methamphetamine abusers.

Authors:  Ain Chung; In Kyoon Lyoo; Seog Ju Kim; Jaeuk Hwang; Soojeong C Bae; Young Hoon Sung; Minyoung E Sim; In Chan Song; Jihyun Kim; Kee Hyun Chang; Perry F Renshaw
Journal:  Int J Neuropsychopharmacol       Date:  2006-12-06       Impact factor: 5.176

4.  Neurocognitive deficits in cocaine users: a quantitative review of the evidence.

Authors:  Diana Jovanovski; Suzanne Erb; Konstantine K Zakzanis
Journal:  J Clin Exp Neuropsychol       Date:  2005-02       Impact factor: 2.475

5.  Methamphetamine-related stroke: four cases.

Authors:  J A Perez; E L Arsura; S Strategos
Journal:  J Emerg Med       Date:  1999 May-Jun       Impact factor: 1.484

6.  Methamphetamine effects on cognitive processing during extended wakefulness.

Authors:  D A Wiegmann; R R Stanny; D L McKay; D F Neri; A H McCardie
Journal:  Int J Aviat Psychol       Date:  1996

Review 7.  Attention-deficit/hyperactivity disorder in adults: an overview.

Authors:  S V Faraone; J Biederman; T Spencer; T Wilens; L J Seidman; E Mick; A E Doyle
Journal:  Biol Psychiatry       Date:  2000-07-01       Impact factor: 13.382

8.  Prefrontal grey-matter changes in short-term and long-term abstinent methamphetamine abusers.

Authors:  Seog Ju Kim; In Kyoon Lyoo; Jaeuk Hwang; Ain Chung; Young Hoon Sung; Jihyun Kim; Do-Hoon Kwon; Kee Hyun Chang; Perry F Renshaw
Journal:  Int J Neuropsychopharmacol       Date:  2005-06-28       Impact factor: 5.176

9.  A comparison of injection and non-injection methamphetamine-using HIV positive men who have sex with men.

Authors:  Shirley J Semple; Thomas L Patterson; Igor Grant
Journal:  Drug Alcohol Depend       Date:  2004-11-11       Impact factor: 4.492

10.  Psychiatric and substance dependence comorbidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment.

Authors:  Steven Shoptaw; James Peck; Cathy J Reback; Erin Rotheram-Fuller
Journal:  J Psychoactive Drugs       Date:  2003-05
View more
  276 in total

1.  A quantitative meta-analysis of neurocognitive functioning in posttraumatic stress disorder.

Authors:  J Cobb Scott; Georg E Matt; Kristen M Wrocklage; Cassandra Crnich; Jessica Jordan; Steven M Southwick; John H Krystal; Brian C Schweinsburg
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

2.  Prospective memory deficits in Ecstasy users: effects of longer ongoing task delay interval.

Authors:  Michael Weinborn; Steven Paul Woods; Claire Nulsen; Katherine Park
Journal:  J Clin Exp Neuropsychol       Date:  2011-11-03       Impact factor: 2.475

3.  Effects of exposure to amphetamine derivatives on passive avoidance performance and the central levels of monoamines and their metabolites in mice: correlations between behavior and neurochemistry.

Authors:  Kevin Sean Murnane; Shane Alan Perrine; Brendan James Finton; Matthew Peter Galloway; Leonard Lee Howell; William Edward Fantegrossi
Journal:  Psychopharmacology (Berl)       Date:  2011-10-13       Impact factor: 4.530

Review 4.  Cognitive enhancement as a treatment for drug addictions.

Authors:  Mehmet Sofuoglu; Elise E DeVito; Andrew J Waters; Kathleen M Carroll
Journal:  Neuropharmacology       Date:  2012-06-23       Impact factor: 5.250

5.  Impulsivity and executive functions in polysubstance-using rave attenders.

Authors:  Antonio Verdejo-García; María Del Mar Sánchez-Fernández; Luisa María Alonso-Maroto; Fermín Fernández-Calderón; Jose C Perales; Oscar Lozano; Miguel Pérez-García
Journal:  Psychopharmacology (Berl)       Date:  2010-04-13       Impact factor: 4.530

6.  Working memory deficits affect risky decision-making in methamphetamine users with attention-deficit/hyperactivity disorder.

Authors:  Nichole A Duarte; Steven Paul Woods; Alexandra Rooney; J Hampton Atkinson; Igor Grant
Journal:  J Psychiatr Res       Date:  2012-02-02       Impact factor: 4.791

7.  Atypical dopamine transporter inhibitors attenuate compulsive-like methamphetamine self-administration in rats.

Authors:  Brendan J Tunstall; Chelsea P Ho; Jianjing Cao; Janaína C M Vendruscolo; Brooke E Schmeichel; Rachel D Slack; Gianluigi Tanda; Alexandra J Gadiano; Rana Rais; Barbara S Slusher; George F Koob; Amy H Newman; Leandro F Vendruscolo
Journal:  Neuropharmacology       Date:  2017-12-05       Impact factor: 5.250

8.  Elevated neurobehavioral symptoms are associated with everyday functioning problems in chronic methamphetamine users.

Authors:  Jordan E Cattie; Steven Paul Woods; Jennifer E Iudicello; Carolina Posada; Igor Grant
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2012       Impact factor: 2.198

9.  Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors.

Authors:  Anantha Ram Nookala; Daniel C Schwartz; Nitish S Chaudhari; Alexy Glazyrin; Edward B Stephens; Nancy E J Berman; Anil Kumar
Journal:  Brain Behav Immun       Date:  2018-05-02       Impact factor: 7.217

10.  Methamphetamine compromises gap junctional communication in astrocytes and neurons.

Authors:  Paul Castellano; Chisom Nwagbo; Luis R Martinez; Eliseo A Eugenin
Journal:  J Neurochem       Date:  2016-04-18       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.